| Primary |
| Benign Prostatic Hyperplasia |
52.4% |
| Drug Use For Unknown Indication |
15.4% |
| Product Used For Unknown Indication |
12.0% |
| Hypertension |
2.7% |
| Diabetes Mellitus |
2.4% |
| Cardiac Failure |
2.1% |
| Dysuria |
2.1% |
| Nasopharyngitis |
2.1% |
| Hyperlipidaemia |
1.3% |
| Constipation |
1.1% |
| Gastrointestinal Disorder |
1.1% |
| Gastric Ulcer |
0.8% |
| Gastritis |
0.8% |
| Atrial Fibrillation |
0.5% |
| Cystitis |
0.5% |
| Dementia |
0.5% |
| Dermatitis |
0.5% |
| Glaucoma |
0.5% |
| Hypertonic Bladder |
0.5% |
| Infection |
0.5% |
|
| Liver Function Test Abnormal |
12.5% |
| Urinary Retention |
12.5% |
| Hepatic Function Abnormal |
11.4% |
| Myocardial Infarction |
8.0% |
| Interstitial Lung Disease |
6.8% |
| Cardiac Failure |
4.5% |
| Hypoglycaemia |
4.5% |
| Macular Degeneration |
4.5% |
| Gamma-glutamyltransferase Increased |
3.4% |
| Haematuria |
3.4% |
| Loss Of Consciousness |
3.4% |
| Myalgia |
3.4% |
| Testicular Neoplasm |
3.4% |
| Tinnitus |
3.4% |
| White Blood Cell Count Increased |
3.4% |
| Anaemia |
2.3% |
| Aspartate Aminotransferase Increased |
2.3% |
| Blood Glucose Increased |
2.3% |
| Chest Pain |
2.3% |
| Diabetes Mellitus |
2.3% |
|
| Secondary |
| Benign Prostatic Hyperplasia |
54.8% |
| Atrial Fibrillation |
9.7% |
| Constipation |
6.5% |
| Diabetes Mellitus |
6.5% |
| Hypertension |
6.5% |
| Gastric Ulcer |
3.2% |
| Haemorrhage |
3.2% |
| Hypertonic Bladder |
3.2% |
| Pollakiuria |
3.2% |
| Prostatic Cyst |
3.2% |
|
| Haematuria |
10.0% |
| Liver Function Test Abnormal |
10.0% |
| Medication Error |
10.0% |
| Nipple Exudate Bloody |
10.0% |
| Platelet Count Decreased |
10.0% |
| Pulmonary Embolism |
10.0% |
| Pyrexia |
10.0% |
| Somnolence |
10.0% |
| Tongue Discolouration |
10.0% |
| Urinary Retention |
10.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
16.5% |
| Benign Prostatic Hyperplasia |
14.6% |
| Dysuria |
8.7% |
| Epilepsy |
6.8% |
| Hypertension |
6.3% |
| Chronic Hepatitis C |
4.9% |
| Colon Cancer Metastatic |
4.9% |
| Colorectal Cancer |
4.9% |
| Chronic Obstructive Pulmonary Disease |
3.9% |
| Hypertonic Bladder |
3.9% |
| Type 2 Diabetes Mellitus |
3.4% |
| Gastritis |
2.9% |
| Insomnia |
2.9% |
| Hyperuricaemia |
2.4% |
| Neurosis |
2.4% |
| Parkinson's Disease |
2.4% |
| Prophylaxis |
2.4% |
| Atrial Fibrillation |
1.9% |
| Colitis Ulcerative |
1.9% |
| Dementia Alzheimer's Type |
1.9% |
|
| Interstitial Lung Disease |
17.1% |
| Renal Impairment |
11.4% |
| Drug Eruption |
5.7% |
| Eosinophilic Pneumonia |
5.7% |
| Haemoglobin Decreased |
5.7% |
| Malaise |
5.7% |
| Platelet Count Decreased |
5.7% |
| Thermal Burn |
5.7% |
| Urinary Retention |
5.7% |
| Blood Pressure Immeasurable |
2.9% |
| Cardiac Failure |
2.9% |
| Cardio-respiratory Arrest |
2.9% |
| Cholinergic Syndrome |
2.9% |
| Death |
2.9% |
| Dementia |
2.9% |
| Depressed Level Of Consciousness |
2.9% |
| Dyspnoea |
2.9% |
| Hyponatraemia |
2.9% |
| Injection Site Swelling |
2.9% |
| Loss Of Consciousness |
2.9% |
|
